September 6, 2011
MESSAGE FROM THE DIRECTOR
Stan Gerson, MD
Case CCC Strategic Plan
All members should have recently received a draft of the Case CCC Strategic Plan for 2012-2018. This plan represents the efforts and discussion of the entire membership, Program Leaders, Executive Committee, and institutional leaders. It will be the basis for our renewal application and for institutional commitments for the coming 6 years.
Thoughts on gaps, and critical perspectives and needs are greatly appreciated. You may send any comments to me at firstname.lastname@example.org. All feedback will be discussed by the Executive Committee.
If you would like a copy of the Strategic Plan, please email Gillian Todd at email@example.com.
Thank you for your review and your support of the Cancer Center.
Cancer Center Seminar Series: Interfaces Between Primary and Subspecialty Care Across the Cancer Care Continuum
I want to remind everyone the first Seminar Series presentation of the fall semester will be this Friday, September 9 at 12 pm in BRB 105. Guest speaker, Stephen Taplin, MD, MPH, will discuss Interfaces Between Primary and Subspecialty Care Across the Cancer Care Continuum. Dr. Taplin is Acting Branch Chief of the Process of Care Research Branch (PCRB), Behavioral Research Program (BRP) in the Division of Cancer Control and Population Sciences (DCCPS) at the NCI. He is an internationally recognized expert in the field of cancer screening, and is currently working with a variety of investigators to consider new issues in cancer screening the evaluation of multilevel contextual effects on health care delivery across the cancer continuum.
Please plan on attending this and future seminar series presentations, which will focus on cutting-edge clinical, translational, and basic research topics in cancer.
CASE CCC IN THE NEWS
Research Gives New Hope to Those with Rare Vascular Cancer
Implant Helps Those With Skin Diseases, and Gives Them a Tan Too
UH Pancreatic Cancer Study Focuses on Early Tumor Detection
New Cancer Drug Approved That Eliminates Chemo Horrors
Research Staff Orientation and Continuing Education Sessions
New Research Staff Orientation Session
This orientations session is mandatory for all new SCC and TCI research staff and is open to staff from other departments and institutes conducting clinical trials in oncology. Topics will cover an overview of: Case Comprehensive Cancer Center and P30 grant; joint meetings and initiatives; review and monitoring committees; clinical trials reporting requirements; study and sponsor types; IND/IDE; monitoring and auditing and biostatistics; processes and Standard Operating Procedures; and OnCore Clinical Trials Management System.
Research Staff Continuing Education Sessions
These continuing education sessions are mandatory for all SCC and TCI research staff and is open to staff from other departments and institutes conducting clinical trials in oncology. Topics will cover an overview of the Case Comprehensive Cancer Center, updates and Standard Operating Procedures. Break-out sessions will cover the joint site initiation visit during from several perspectives such as regulatory, nursing, data management and quality assurance.
Please direct any questions to Melissa Kadar, Director of UH/SCC Clinical Trials at melissa.kadar@UHhospitals.org or 216-286-6639.
New Federal Mandate to Report Clinical Trial Results in clinicaltrials.gov
A new federal mandate requires reporting of clinical trial results in clinicaltrials.gov. U.S. Public Law 110-85 (Food and Drug Administration Amendments Act of 2007), Title VIII, Section 801, mandates that certain clinical trials have to be registered and results have to be reported in clinicaltrials.gov. More information is available on the: Protocol Registration System.
The Case CCC Research Coordinator for clinicaltrials.gov has been registering applicable trials in clinicaltrials.gov on the investigators and study teams behalf. This announcement serves as a notification that in the upcoming months, we will be contacting investigators and research teams whose trials have been registered in clinicaltrials.gov to obtain certain information and to assist investigators in reporting trial results. Please direct questions to April Firstencel, Research Coordinator for Clinicaltrials.gov, Case CCC; 216-286-2294; firstname.lastname@example.org.
HHMI Medical Research Fellows Program
The Howard Hughes Medical Institute is accepting applications for the Medical Research Fellows Program, which supports a year of full-time biomedical research training for medical, dental, and veterinary students enrolled in schools in the U.S. The goal of the HHMI Medical Research Fellows Program is to strengthen and expand the nation's pool of medically trained researchers. The fellowships provide funds to support fellows and meet their research- and education-related expenses.
Deadline: January 11, 2012
**All events are open to anyone interested in attending
Happy Labor Day!
Hematology and Oncology Division Research Conference
Immunology Students/Fellows Research in Progress Series
Imaging Solutions in Cancer Management: A Case-based Conference
Hematology/Oncology Fellows Conference
Taussig Cancer Institute Grand Rounds
Hematology/Oncology Fellows Oncology Case Conference
Cancer Center Research in Progress
UPCOMING CANCER CENTER SYMPOSIUMS & EVENTS
ADDITIONAL UPCOMING SEMINARS & EVENTS
First Ascoli Piceno Conference on Gene Vaccination in Cancer
8th International Conference of the Society for Integrative Oncology: Innovating Integrative Oncology: New Science, New Solutions
PREVIOUSLY ANNOUNCED FUNDING OPPORTUNITIES
AACR Team Science Award
Burroughs Wellcome Fund Medical Scientist Career Awards
NIH BULLETIN – Notices and Funding Opportunities
Gillian Irwin Todd
11100 Euclid Avenue, Wearn 149
Cleveland, Ohio 44106-5065
HELP US HELP YOU!
If you have a new grant, recently won an award, or have other newsworthy items, please let us know so we can publicize them in the newsletter and other media outlets. You deserve the accolades!
Send items to email@example.com.